Teva Pharmaceutical Industries (TEVA)
Teva Pharmaceutical Industries Cash and ST Investments
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
TEVA Cash and ST Investments Range, Past 5 Years
| Minimum | 748.00M | Mar 2011 |
| Maximum | 4.878B | Jun 2010 |
| Average | 2.211B |
About Cash and Short Term Investments
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities
Learn More
You may also be interested in these TEVA related companies
TEVA News
$TARO super-cheap at $37 $TEVA $AMRN $PFE $PRGO $MYL $PFE http://stks.co/43a0
about 19 hours ago by imhobutdydd
about 19 hours ago by imhobutdydd
Teva to Present at the Sanford C. Bernstein 28th Annual Strategic Decisions Conference
May 30, 12:33PM Business Wire
May 30, 12:33PM Business Wire
@mydanilo It had nothing to do with those news. That was already priced in. Seems like Patent news regarding $TEVA and $GSK was the trigger.
about 3 days ago by mitrado
about 3 days ago by mitrado
Teva Pharmaceutical Inds, VeriFone Systems Among Stocks Down on Above-average Volume Tuesday
May 29, 4:34PM Fox Business
May 29, 4:34PM Fox Business
$AMRN up following news that $Teva and $PRX lost a bid to sell the generic form of $GSK Lovaza. http://stks.co/41F0
about 3 days ago by abubnic
about 3 days ago by abubnic
Teva (TEVA), Par Pharma (NPRX) said to lose bid to sell the generic form of Glaxo's (GSK) Lovaza
May 29, 3:20PM Street Insider
May 29, 3:20PM Street Insider
Canaccord Genuity Reiterates a 'Buy' on Momenta Pharmaceuticals (MNTA); Copaxone Preview
May 29, 8:24AM Street Insider
May 29, 8:24AM Street Insider
Barclays Maintains an 'Equalweight' on Teva Pharma (TEVA); Adjusting Estimates After Business Update
May 25, 1:21PM Street Insider
May 25, 1:21PM Street Insider
Jeremy Levin is checking all the right boxes at $TEVA. Set realistic expectations, cut the fat/fix what you have, then look for new growth.
about 7 days ago by bradloncar
about 7 days ago by bradloncar
UBS Maintains a 'Buy' on Teva Pharma (TEVA); CEO Highlights From Conference Call
May 25, 10:52AM Street Insider
May 25, 10:52AM Street Insider
$TEVA keeps going up on bad news. WTF!? Can anyone explain this insanity?
about 7 days ago by mitrado
about 7 days ago by mitrado
Canaccord Genuity Maintains a 'Buy' on Teva Pharma (TEVA); Adjusting Estimates; Copaxone Still In Focus
May 25, 9:39AM Street Insider
May 25, 9:39AM Street Insider
UPDATE: Citigroup Reduces PT to $49 on Teva Pharmaceuticals on Lower Estimates
May 25, 8:07AM Benzinga
May 25, 8:07AM Benzinga
Needham & Company Maintains a 'Hold' on Teva Pharma (TEVA); Adjusting Estimates
May 25, 7:55AM Street Insider
May 25, 7:55AM Street Insider
wow $TEVA getting murdered. Puts I alerted this morning at .39 are now at .68.+74% ...but I already alerted to sell at .52 *sighs*
about 8 days ago by OptionRunners
about 8 days ago by OptionRunners
$TEVA 37.5x June puts, just alerted to sell at .52 from my alert this morning at .39. Quick +33.3% gain.
about 8 days ago by OptionRunners
about 8 days ago by OptionRunners
Nice drop on $TEVA from the highs! Lowered 2012 guidance. Alerted the 37.5x June puts this morning at .39. Now at .50 +28.2%
about 8 days ago by OptionRunners
about 8 days ago by OptionRunners
Blueberries, Gold Bond, Ovaltine and Obesity: The Makings for a Very Good Story
May 23, 5:03PM Benzinga
May 23, 5:03PM Benzinga
Bob McDonald’s Quandary: Save the World or Maintain P&G’s Dividend, Yielding 3.5% http://stks.co/3xc5 $PG $K $DMND $TEVA
about 9 days ago by ycharts
about 9 days ago by ycharts
@bradloncar Thanks. I guess I just have a suspicious mind. This is the same guy that sits on $TEVA board,right ?? newly elected 3 yrs.
about 10 days ago by stockhound
about 10 days ago by stockhound
W his left-over pocket change, Dr. Frost also invests in $PBTH. Made his fortune w investments in $TEVA. $OPK http://stks.co/3w1h
about 10 days ago by abubnic
about 10 days ago by abubnic
$SBUX $PCLN $TEVA $CSCO $QQQ
15 Most Oversold Nasdaq 100 Stocks
http://stks.co/3vBl
about 11 days ago by TomAspray
about 11 days ago by TomAspray
Canaccord Genuity on Pharmaceuticals: Generic Valuation at Historical Trough Level Ahead of Meetings
May 21, 10:05AM Street Insider
May 21, 10:05AM Street Insider
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TEVA | 38.47 | -0.72 | -1.84% | 36.91B |
| TEU | 7.85 | -0.08 | -1.01% | |
| TESS | 18.21 | -0.95 | -4.96% | 149.06M |
| TER | 13.67 | -0.78 | -5.40% | 2.694B |
| TEO | 11.96 | -0.15 | -1.24% | 2.384B |
| Y | 326.19 | -2.81 | -0.85% | 2.813B |
| XXIA | 10.28 | -0.30 | -2.84% | 748.32M |
| XWES | 3.40 | -0.11 | -3.13% | 40.36M |
| XUE | 3.46 | -0.13 | -3.62% | 248.32M |
| XTXI | 13.32 | -0.19 | -1.41% | 640.24M |
